Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Dyfynnu hyn

@article{32fb523c81ac49df800fbadccadaae99,

title = "Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.",

keywords = "PHARMACOLOGY \& PHARMACY",

author = "D. Hughes and D.A. Hughes and D. Dubois",

year = "2004",

month = jan,

day = "1",

language = "English",

volume = "22",

pages = "1047--1059",

journal = "Pharmacoeconomics",

issn = "1170-7690",

publisher = "Adis",

number = "16",

}

TY - JOUR

T1 - Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

AU - Hughes, D.

AU - Hughes, D.A.

AU - Dubois, D.

PY - 2004/1/1

Y1 - 2004/1/1

KW - PHARMACOLOGY & PHARMACY

M3 - Article

SN - 1170-7690

VL - 22

SP - 1047

EP - 1059

JO - Pharmacoeconomics

JF - Pharmacoeconomics

IS - 16

ER -